Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oxygen Biotherapeutics hires leader for new product division

This article was originally published in Clinica

Executive Summary

Oxygen Biotherapeutics (Costa Mesa, California), a company that is commercialising innovative medical devices and pharmaceuticals in the field of oxygen therapeutics and continuous substrate monitoring, has appointed Robert Diegelmann head of the company’s new wound care division. Dr Diegelmann is professor of biochemistry and molecular biology, anatomy and emergency medicine at Virginia Commonwealth University (VCU) Medical Center. He is already familiar with the company’s Oxycyte product for wound care and is considered to be a specialist in the field: “I view Bob Diegelmann as VCU’s wound care guru and I’m thrilled that he has contracted to be in charge of getting our topical and clinical wound indications to market,” said the company’s chairman and CEO, Chris Stern. The company’s priority market is therapeutics for traumatic brain injury.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041256

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel